Aperio Group, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 100 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$179,000
+73.8%
51,178
+19.7%
0.00%
Q3 2020$103,000
+202.9%
42,767
+128.8%
0.00%
Q2 2020$34,000
-32.0%
18,689
-41.4%
0.00%
Q1 2020$50,000
-35.1%
31,908
-11.8%
0.00%
Q4 2019$77,000
+28.3%
36,184
+13.4%
0.00%
Q3 2019$60,000
+275.0%
31,908
+411.7%
0.00%
Q2 2019$16,000
-81.0%
6,236
-73.1%
0.00%
-100.0%
Q2 2014$84,000
-9.7%
23,181
-3.1%
0.00%0.0%
Q1 2014$93,000
+40.9%
23,933
+3.2%
0.00%0.0%
Q4 2013$66,00023,1920.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders